
|Videos|December 9, 2021
Dr. Venkat emphasizes individualized care for upper tract urothelial carcinoma cases
Author(s)Urology Times staff
“We’re not doing enough lymph node dissections in upper tract disease,” says Siv Venkat, MD, FRCSC.
Advertisement
In this video, Siv Venkat, MD, FRCSC, discusses the takeaways and further research associated with the study, “Comparison of radical nephroureterectomy and segmental ureterectomy in upper tract urothelial carcinoma,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Venkat is a urologic oncology fellow at Weill Cornell Medicine and New York-Presbyterian Hospital in New York City, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
4
Prof Declan Murphy on interpreting the PROTEUS trial in localized prostate cancer
5











